Helicobacter pylori populations in Peruvian patients

D E Berg1, R H Gilman, J Lelwala-Guruge

  • 1Department of Molecular Microbiology, Washington University Medical School, St. Louis, Missouri 63110, USA. BERG@borcim.wustl@edu

Insights

This study on Helicobacter pylori in Peru found that most patients carried genetically similar bacterial strains, suggesting host selection. Frequent metronidazole use may explain mixed susceptible and resistant strains.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Helicobacter pylori exhibits significant genetic diversity.
  • Understanding strain variation is crucial for elucidating colonization, disease, and evolution.
  • Studying isolates from individual patients offers insights into host-pathogen interactions.

Purpose of the Study:

  • To characterize Helicobacter pylori strains from Peruvian patients.
  • To investigate the relationship between metronidazole resistance and genetic diversity (genotype).
  • To explore factors influencing H. pylori strain selection within hosts.

Main Methods:

  • Analysis of H. pylori isolates from 24 patients at the Japanese-Peruvian Polyclinic in Lima, Peru.
  • Determination of metronidazole susceptibility or resistance.
  • Random Amplified Polymorphic DNA (RAPD) fingerprinting to assess overall bacterial genotype.

Main Results:

  • Both metronidazole-susceptible and -resistant strains were found in 13 out of 24 patients.
  • Strains of more than one RAPD type (genotype) were isolated from only seven patients.
  • Most patients harbored genetically homogeneous H. pylori strains.

Conclusions:

  • Homogeneity in RAPD fingerprints suggests selection for specific H. pylori genotypes during chronic infection.
  • Host factors likely play a role in selecting for advantageous bacterial traits.
  • The co-carriage of related susceptible and resistant strains may result from frequent metronidazole use and alternating selection pressures.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...